(Q73126432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

1 reference

Z M Khan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K L Rascati

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J M Koeller

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

43-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10539121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199916010-00005

1 November 2019

exact match

0 references

cites work

Carboplatin versus cisplatin

1 reference

12 December 2020

The costs of carboplatin treatment

1 reference

12 December 2020

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

1 reference

12 December 2020

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.

1 reference

12 December 2020